Thomas Bhatt

Thomas Bhatt focuses on imaging strategies in testicular cancer management, including staging, treatment response assessment, and post-chemotherapy evaluation of residual masses. His research has evaluated PET-CT and MRI protocols for assessing retroperitoneal lymph node status and guiding decisions about retroperitoneal lymph node dissection in seminoma. He has characterized imaging features that predict viable tumor versus necrosis/teratoma in residual post-chemotherapy masses. His work informs evidence-based imaging surveillance protocols that balance detection of recurrence with radiation exposure in young testicular cancer survivors.